Cargando…

Case Report: Life-Threatening Macrophage Activation Syndrome With Fulminant Myocarditis Successfully Rescued by High Dose Intravenous Anakinra

Macrophage activation syndrome (MAS) is a rare, potentially life-threatening, condition triggered by infections or flares in rheumatologic and neoplastic diseases. The mainstay of treatment includes high dose corticosteroids, intravenous immunoglobulins and immunosuppressive drugs although, more rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meneghel, Alessandra, Martini, Giorgia, Amigoni, Angela, Pettenazzo, Andrea, Padalino, Massimo, Zulian, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848179/ https://www.ncbi.nlm.nih.gov/pubmed/33537271 http://dx.doi.org/10.3389/fped.2020.635080

Ejemplares similares

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

Case report: Exploring under the tip of the iceberg: A case series of “self-limiting” multisystem inflammatory syndrome in children
por: Meneghel, Alessandra, et al.
Publicado: (2022)

Prognostic role of euthyroid sick syndrome in MIS-C: results from a single-center observational study
por: Fastiggi, Michele, et al.
Publicado: (2023)

Impact of guidelines implementation on empiric antibiotic treatment for pediatric uncomplicated osteomyelitis and septic arthritis over a ten-year period: Results of the ELECTRIC study (ostEomyeLitis and sEptiC arThritis tReatment in children)
por: Minotti, Chiara, et al.
Publicado: (2023)

86. Intravenous anakinra treatment in a rare case of macrophage activation syndrome presenting as fulminant liver failure
por: Ghuman, Abeer, et al.
Publicado: (2018)

Hypoperfusion With Vomiting, Abdominal Pain, or Dizziness and Convulsions: An Alert to Fulminant Myocarditis in Children
por: Zhu, Angang, et al.
Publicado: (2020)

Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19
por: Hsu, Hao-Ting, et al.
Publicado: (2023)

Factors Associated With In-hospital Mortality of Children With Acute Fulminant Myocarditis on Extracorporeal Membrane Oxygenation
por: Lee, En-Pei, et al.
Publicado: (2020)

Myoglobin and left ventricular ejection fraction as predictive markers for death in children with fulminant myocarditis
por: Xie, Tingting, et al.
Publicado: (2022)

Anakinra treats fulminant myocarditis from Neisseria meningitidis septicaemia and haemophagocytic lymphohistiocytosis: a case report
por: Thomson, Ross J, et al.
Publicado: (2021)

Long Non-coding RNA Expression Profile and Functional Analysis in Children With Acute Fulminant Myocarditis
por: Liu, Qingqing, et al.
Publicado: (2019)

The Clinical Features of Children With Acute Fulminant Myocarditis and the Diagnostic and Follow-Up Value of Cardiovascular Magnetic Resonance
por: Lv, Jianli, et al.
Publicado: (2019)

A Case of Influenza Associated Fulminant Myocarditis Successfully Treated with Intravenous Peramivir
por: Baik, Seung Hee, et al.
Publicado: (2015)

Intravenous administration of anakinra in children with macrophage activation syndrome
por: Phadke, Omkar, et al.
Publicado: (2021)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
por: Li, Yining, et al.
Publicado: (2019)

Successful rescue of fulminant myocarditis with mechanical circulatory support and immunosuppression therapy: A case report
por: Zhou, Chi
Publicado: (2023)

Coronavirus Associated Fulminant Myocarditis Successfully Treated With Intravenous Immunoglobulin and Extracorporeal Membrane Oxygenation
por: Rao, Sangeetha, et al.
Publicado: (2014)

Juvenile diabetes and systemic sclerosis: just a coincidence?
por: Mastrangelo, Greta, et al.
Publicado: (2022)

Management of Hepatitis A-induced Macrophage Activation Syndrome With Anakinra in Systemic Juvenile Idiopathic Arthritis: A Case Report
por: AlNouwaiser, Deena N, et al.
Publicado: (2022)

ECMO as an effective rescue therapeutic for fulminant myocarditis complicated with refractory cardiac arrest
por: Li, Ya-Ting, et al.
Publicado: (2017)

Fulminant Eosinophilic Myocarditis: A Rare and Life-Threatening Presentation of Eosinophilic Granulomatosis With Polyangiitis
por: Lopes, Pedro M., et al.
Publicado: (2020)

Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: A retrospective study
por: YU, DAN-QING, et al.
Publicado: (2014)

Early detection of ventricular dysfunction in juvenile systemic sclerosis by speckle tracking echocardiography
por: Civieri, Giovanni, et al.
Publicado: (2020)

Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma
por: Martini, Giorgia, et al.
Publicado: (2020)

Case Report: Successful Treatment of a Child With COVID-19 Reinfection-Induced Fulminant Myocarditis by Cytokine-Adsorbing oXiris® Hemofilter Continuous Veno-Venous Hemofiltration and Extracorporeal Membrane Oxygenation
por: Phan, Phuc H., et al.
Publicado: (2022)

Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?
por: Fingerhutová, Šárka, et al.
Publicado: (2022)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study
por: Martini, Giorgia, et al.
Publicado: (2023)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
por: Monteagudo, Luke Adam, et al.
Publicado: (2020)

Intravenous anakinra for cytokine storm syndromes
por: Jamilloux, Yvan, et al.
Publicado: (2020)

Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
por: Gambacorta, Alessandro, et al.
Publicado: (2020)

Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic
por: Della Paolera, Sara, et al.
Publicado: (2021)

Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
por: Çaǧlayan, Şengül, et al.
Publicado: (2022)

Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study
por: Licciardi, Francesco, et al.
Publicado: (2023)

Systemic sclerosis sine scleroderma in children
por: Zulian, Francesco, et al.
Publicado: (2021)

Hyperinflammation in Two Severe Acute Respiratory Syndrome Coronavirus 2-Infected Adolescents Successfully Treated With the Interleukin-1 Inhibitor Anakinra and Glucocorticoids
por: Calò Carducci, Francesca I., et al.
Publicado: (2020)

Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome
por: Mehta, Puja, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9j5q21814b5jcolcrp2m1toiug